Aktien Sensor

Kenvue, a consumer healthcare company spun off from Johnson & Johnson in 2023, is facing pressure from TOMS Capital Investment Management to consider a sale or separation of its assets.

Kenvue has reached a settlement with activist investor Starboard Value, agreeing to appoint three new directors to its board in a move aimed at addressing investor concerns.